• Manufacturing

Evonetix expands facilities and relocates to central Cambridge, UK

Evonetix, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has moved to Coldham’s Business Park, Cambridge, UK. The new facility will enable the continued growth of the Company as it continues in its mission to develop a desktop DNA synthesis platform based on its proprietary silicon chip.

Enterprise Therapeutics awarded up to £5.7M ($7M) from Cystic Fibrosis Foundation to Support Clinical Development of Novel Chloride Channel Modulator

Brighton, UK, 15 October 2019: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, today announced it has been awarded up to £5.7M ($7M) funding under the Therapeutics Development Award programme from the Cystic Fibrosis Foundation.

MedAnnex begins cell line development at FUJIFILM Diosynth

Edinburgh-based biotechnology company MedAnnex today announced that cell line development for the generation of its anti-Annexin A1 antibodies is under way, at FUJIFILM Diosynth Biotechnologies’ (Fujifilm) Billingham, UK site.

Cellexus go global with new distribution network

Biotech company, Cellexus International Ltd, have increased their distributor network to bring their CellMaker bioreactor range to a global market.

Cobra Biologics and Symbiosis Complete £4.8m Viral Vector Supply Chain Collaboration

Developing world-leading capabilities in drug substance and drug product viral vector production for gene and immunotherapy.

Oxford Biomedica named as winner of The Oxford Science Park Innovation Award 2019

Leading gene therapy manufacturer recognised as part of Oxfordshire Business Awards Oxford, UK, June 18 2019 - Its work on life-changing treatments for serious diseases has earned Oxford Biomedica, a leading gene and cell therapy group, The Oxford Science Park Innovation Award 2019.

Video of the week | How Engineers Move Medicine Around The World

Medicines have complex storage and transportation needs, and getting medicines to remote locations requires lots of planning, clever engineering and infrastructure. Check out this video from SciShow on YouTube to find out more about how medicines are transported around the world. 

Coulter Partners places Head of Manufacturing for Nanoform

Coulter Partners was very pleased to partner once again with innovative drug enabling nanotechnology company, Nanoform to secure the appointment of Dr David Rowe as its Head of Manufacturing. The new role will strengthen Nanoform’s manufacturing organization to efficiently deliver commercial APIs for global partners.

Locate Bio receives additional £2.0 million investment from Mercia to expand gene and cell therapy pipeline

Locate Bio Ltd has received an additional £2.0 million of investment from Mercia Technologies PLC and its third party fund, the Midlands Engine Investment Fund to expand the application of its technologies, including its promising gene therapy technology IntraStem™, into new high value therapy areas to both broaden its in-house development pipeline and provide additional partnering opportunities.

Video of the Week | National Apprenticeship Week 2019 | Advanced Therapies

During National Apprenticeship Week apprentices and participating employers gathered at Oxford BioMedica to discuss how the first of its kind advanced therapies apprenticeship programme is key to meeting the industry demands for advanced therapies. Dr Ian Campbell, interim Executive Chair, Innovate UK, delivered the keynote speech and highlighted the Government’s commitment to the programme. Other highlights of the day included a Q&A session with current apprentices and the launch of three new programmes in regulatory affairs, senior management and the Scottish modern apprenticeship in life sciences.